Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
63,913.28 +1,596.65 (+2.56%) CMC Crypto 200
1,371.97 +59.34 (+4.52%)
Bio-Rad Laboratories, Inc. (BIO)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 7.98B |
| Enterprise value | 7.78B |
| Trailing P/E | N/A |
| Forward P/E | 25.13 |
| PEG ratio (5-yr expected) | 1.07 |
| Price/sales (ttm) | 3.06 |
| Price/book (mrq) | 0.91 |
| Enterprise value/revenue | 2.91 |
| Enterprise value/EBITDA | -11.88 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.88 |
| 52-week change 3 | -39.43% |
| S&P500 52-week change 3 | 20.07% |
| 52-week high 3 | 473.50 |
| 52-week low 3 | 261.59 |
| 50-day moving average 3 | 329.10 |
| 200-day moving average 3 | 340.27 |
Share statistics
| Avg vol (3-month) 3 | 207.74k |
| Avg vol (10-day) 3 | 218.5k |
| Shares outstanding 5 | 23.42M |
| Implied shares outstanding 6 | 28.52M |
| Float 8 | 19.96M |
| % held by insiders 1 | 15.24% |
| % held by institutions 1 | 81.71% |
| Shares short (28 Mar 2024) 4 | 564.75k |
| Short ratio (28 Mar 2024) 4 | 3.22 |
| Short % of float (28 Mar 2024) 4 | 3.17% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.98% |
| Shares short (prior month 29 Feb 2024) 4 | 503.41k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 08 Mar 2002 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -23.86% |
| Operating margin (ttm) | 14.24% |
Management effectiveness
| Return on assets (ttm) | 1.77% |
| Return on equity (ttm) | -6.94% |
Income statement
| Revenue (ttm) | 2.67B |
| Revenue per share (ttm) | 91.45 |
| Quarterly revenue growth (yoy) | -6.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 511.6M |
| Net income avi to common (ttm) | -637.32M |
| Diluted EPS (ttm) | -21.82 |
| Quarterly earnings growth (yoy) | -57.80% |
Balance sheet
| Total cash (mrq) | 1.61B |
| Total cash per share (mrq) | 56.35 |
| Total debt (mrq) | 1.41B |
| Total debt/equity (mrq) | 16.08% |
| Current ratio (mrq) | 5.83 |
| Book value per share (mrq) | 306.51 |
Cash flow statement
| Operating cash flow (ttm) | 374.9M |
| Levered free cash flow (ttm) | 170.82M |
© 2024 Yahoo. All rights reserved.